SOBR logo

SOBR SAFE INC

SOBRNASDAQ
πŸ† #4312 by market capUS Equity
$0.59β–Ό $0.00 (βˆ’0.68%)
Market closed Β· at close
1hβ€”
24hβ–Ό 0.7%
7dβ–² 10.6%
14dβ–Ό 1.9%
30dβ–Ό 50.3%
1yβ–Ό 83.7%
🏦Market Cap
$2M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+71.0%
High Growth
πŸ“ŠGross Margin
53.4%
Healthy
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
3.9x
Fair
Otter Score
52
Weak

Trading Snapshot

Day Range
$0.58 – $0.59
52-Week Range
$0.35 – $3.97
Volume
$3.08B
Avg Volume
$3.54B
Shares Outstanding
2.8M
Next Earnings
Sep 20, 2026

Fundamentals Snapshot

Annual Revenue
$437,421
Last Q Revenue
$79,003
P/E Ratio
β€”
P/S Ratio
3.9x
EPS (TTM)
$-5.57
Dividend Yield
β€”

Why Investors Own SOBR

  • βœ“High-growth profile β€” revenue up +34.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 63% gross margin and 24% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$437,421β–² +32.9% YoY
Gross Margin (TTM)
63.1%β–² +2.8% YoY
Operating Income (TTM)
$53,365β–² +32.9% YoY
Free Cash Flow (TTM)
$105,856β–² +32.9% YoY

About SOBR SAFE INC

SOBR Safe, Inc. specializes in developing non-intrusive technologies for alcohol detection and identity confirmation. The company's offerings include SOBRcheck, a fixed device for identification and continuous alcohol monitoring, and SOBRsure, a wearable band designed to detect alcohol transdermally. These solutions are powered by the SOBRSafe software platform, which manages their core non-invasive alcohol detection and identity verification functionalities. Headquartered in Greenwood Village, Colorado, the enterprise was established in 2004 as TransBiotec, Inc., before officially rebranding as SOBR Safe, Inc. in March 2020.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
52/100

Analyst Price Target

β“˜
Average Target
$0.76
β–² +30.3% Upside
High Target$0.89
Low Target$0.61
Based on 26 analysts

Latest News & Updates